Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Post by CleverInvestor2on Sep 10, 2020 8:58pm
256 Views
Post# 31540362

One of the lucky ones

One of the lucky onesI've been investing in trillium since the low 70 cent range... added some more below $1 and more around $6.60. Sold a few but hold the moajority. I was considering adding more around the $10 mark but that's long gone. I'm glad trillium has been successful so far with their medication. I honestly believe withing a couple years, trillium will be trading around $50... most likely a buy out....

In the near future, before year end, $20 is possible and a good indication of where we're headed.
I've been able to save up some more cash so I might add some more while it's still trading below $15US
<< Previous
Bullboard Posts
Next >>